Contagiend Solutions
NYC-based Contagiend Solutions offers innovative products to protect patients from infections due to unsafe medical practices.
Founded
2016NYC-based Contagiend Solutions offers innovative products to protect patients from infections due to unsafe medical practices.
Contagiend Solutions, founded in New York City, aims to minimize the spread of contagious diseases in healthcare settings by eliminating human error through innovative products. The company focuses on protecting patients from viral, bacterial, and fungal infections resulting from unsafe medical injection practices. Their offerings are tailored for hospitals and clinics, addressing critical issues like syringe reuse and medication vial misuse to prevent outbreaks of HIV, hepatitis B, and hepatitis C.
Notable figures associated with Contagiend Solutions include Dr. Manavjeet Sidhu, M.D./M.B.A., who serves as CEO. The organization has made significant strides in enhancing patient safety and has been recognized for its impactful solutions in infection control. By addressing a crucial gap in medical safety protocols, Contagiend Solutions has contributed to reducing the risk of healthcare-associated infections, thereby improving overall public health outcomes.
Companies similar to Contagiend Solutions include HAI Solutions, Equashield, Prevacept Infection Control and KleenGel.
Contagiend Solutions was founded in 2016.
Contagiend Solutions' headquarters is located in New York City, NY, US.
Contagiend Solutions' most recent funding round was for $75k (USD) in June 2016.
As of Jun 1, 2016, Contagiend Solutions has disclosed funding of $75k (USD). Undisclosed round amounts are excluded.
Contagiend Solutions has 5 employees as of Feb 4, 2024.
KleenGel
